Drug · DIN 02402904
NIMENRIX
KITS OF 1 AND 10 CONTAINING: A) SINGLE-DOSE VIAL AND B) DILUENT (0.5 ML PREFILLED SYRINGE)
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 17, 2017; first marketed August 22, 2013.
- Drug Identification Number (DIN)
- 02402904
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Schedule d
- Dosage form
- Kit; Powder For Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen J07AH04
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A | 5 MCG | 0.5 ML |
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C | 5 MCG | 0.5 ML |
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 | 5 MCG | 0.5 ML |
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y | 5 MCG | 0.5 ML |
| TETANUS TOXOID | 44 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 25, 2016: NOC 17720New Drug Submission (NDS) · Transfer of drug identification number
- March 5, 2013: NOC 14176New Drug Submission (NDS)